002412 汉森制药
午间休市 08-21 11:30:00
资讯
新帖
简况
8月20日汉森制药创60日新高，中欧量化先锋混合A基金重仓该股
证券之星 · 08-20 16:40
8月20日汉森制药创60日新高，中欧量化先锋混合A基金重仓该股
异动快报：汉森制药（002412）8月19日9点34分触及涨停板
证券之星 · 08-19 09:41
异动快报：汉森制药（002412）8月19日9点34分触及涨停板
汉森制药：降脂减肥片用于单纯性肥胖
证券之星 · 08-14
汉森制药：降脂减肥片用于单纯性肥胖
股市必读：汉森制药(002412)股东户数3.39万户，较上期增加4.98%
证券之星 · 08-12
股市必读：汉森制药(002412)股东户数3.39万户，较上期增加4.98%
汉森制药：截至2026年7月31日，公司含信用账户合并股东名册的股东总数为
证券之星 · 08-11
汉森制药：截至2026年7月31日，公司含信用账户合并股东名册的股东总数为
股市必读：汉森制药新发布《关于收到全资子公司分红款的公告》
证券之星 · 08-03
股市必读：汉森制药新发布《关于收到全资子公司分红款的公告》
股市必读：汉森制药（002412）新发布《关于收到全资子公司分红款的公告》
证券之星 · 07-31
股市必读：汉森制药（002412）新发布《关于收到全资子公司分红款的公告》
汉森制药收到子公司永孜堂2亿元现金分红
财中社 · 07-30
汉森制药收到子公司永孜堂2亿元现金分红
汉森制药（002412）披露全资子公司利润分配公告，7月28日股价下跌4.11%
证券之星 · 07-28
汉森制药（002412）披露全资子公司利润分配公告，7月28日股价下跌4.11%
7月23日汉森制药（002412）龙虎榜数据：机构净买入4425.6万元（3日）
证券之星 · 07-23
7月23日汉森制药（002412）龙虎榜数据：机构净买入4425.6万元（3日）
异动快报：汉森制药（002412）7月23日9点38分触及涨停板
证券之星 · 07-23
异动快报：汉森制药（002412）7月23日9点38分触及涨停板
7月22日汉森制药涨10.00%，中欧量化先锋混合A基金重仓该股
证券之星 · 07-22
7月22日汉森制药涨10.00%，中欧量化先锋混合A基金重仓该股
7月15日汉森制药涨9.49%，中欧量化先锋混合A基金重仓该股
证券之星 · 07-15
7月15日汉森制药涨9.49%，中欧量化先锋混合A基金重仓该股
汉森制药：预计2026年1-6月归属净利润盈利1.03亿元至1.16亿元
证券之星 · 07-14
汉森制药：预计2026年1-6月归属净利润盈利1.03亿元至1.16亿元
6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股
证券之星 · 06-15
6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股
汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%
证券之星 · 06-02
汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%
汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%
证券之星 · 05-26
汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%
汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%
证券之星 · 05-25
汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%
股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%
证券之星 · 05-11
股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%
汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为
证券之星 · 05-08
汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为
加载更多
公司概况
公司名称：
湖南汉森制药股份有限公司
所属行业：
医药制造业
上市日期：
2010-05-25
主营业务：
湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。
发行价格：
35.80
{"stockData":{"symbol":"002412","market":"SZ","secType":"STK","nameCN":"汉森制药","latestPrice":10.19,"timestamp":1787286621000,"preClose":9.26,"halted":0,"volume":21258316,"delay":0,"changeRate":0.1004,"floatShares":498000000,"shares":503000000,"eps":0.4477,"marketStatus":"午间休市","change":0.93,"latestTime":"08-21 11:30:00","open":10.19,"high":10.19,"low":10.19,"amount":217000000,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":10.19,"bidSize":181936,"shortable":0,"etf":0,"ttmEps":0.4477,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787288400000},"marketStatusCode":3,"adr":0,"adjPreClose":9.26,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":10.19,"lowLimit":8.33,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":503200000,"isCdr":false,"pbRate":1.92,"roa":"--","peRate":22.760777,"roe":"1.6%","epsLYR":0.3937,"committee":0,"marketValue":5128000000,"turnoverRate":0.0427,"status":0,"floatMarketCap":5073000000},"requestUrl":"/m/hq/s/002412","defaultTab":"news","newsList":[{"id":"2660402719","title":"8月20日汉森制药创60日新高，中欧量化先锋混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402719","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660402719?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:40","pubTimestamp":1787215234,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日汉森制药涨9.98%创60日新高，收盘报9.26元，换手率0.87%，成交量4.35万手，成交额4026.34万元。重仓汉森制药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为中欧基金的中欧量化先锋混合A。中欧量化先锋混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660416815","title":"异动快报：汉森制药（002412）8月19日9点34分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2660416815","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660416815?lang=zh_cn&edition=full","pubTime":"2026-08-19 09:41","pubTimestamp":1787103696,"startTime":"0","endTime":"0","summary":"证券之星8月19日盘中消息，9点34分汉森制药（002412）触及涨停板。其所属行业中药目前上涨。领涨股为汉森制药。该股为流感，农业种植，中药概念热股。8月18日的资金流向数据方面，主力资金净流入677.96万元，占总成交额2.21%，游资资金净流入1047.94万元，占总成交额3.41%，散户资金净流出1725.89万元，占总成交额5.62%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081900009965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0239","BK0039","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659199573","title":"汉森制药：降脂减肥片用于单纯性肥胖","url":"https://stock-news.laohu8.com/highlight/detail?id=2659199573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659199573?lang=zh_cn&edition=full","pubTime":"2026-08-14 08:48","pubTimestamp":1786668490,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)08月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好，贵公司目前哪些产品能够应用于减肥药呢？公司是否会进入减肥药行业呢？汉森制药回复：尊敬的投资者您好，公司全资子公司云南永孜堂制药有限公司的在销产品降脂减肥片主要功能为滋补肝肾，养益精血，扶正固本，通络定痛，健脾痰，明目生津，润肠通便。用于各型高血脂症，心脑血管硬化，单纯性肥胖，习惯性便秘，痔疮出血。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400006621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912579","title":"股市必读：汉森制药(002412)股东户数3.39万户，较上期增加4.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912579","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912579?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:06","pubTimestamp":1786467974,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，汉森制药报收于7.23元，下跌0.55%，换手率5.38%，成交量26.77万手，成交额1.95亿元。股本股东变化：截至2026年7月31日，汉森制药股东户数为3.39万户，较4月30日增长4.98%。交易信息汇总资金流向8月11日主力资金净流出1610.67万元，占总成交额8.28%；游资资金净流出1012.45万元，占总成交额5.2%；散户资金净流入2623.12万元，占总成交额13.48%。户均持股数量由上期的1.56万股减少至1.48万股，户均持股市值为10.01万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963899","title":"汉森制药：截至2026年7月31日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658963899?lang=zh_cn&edition=full","pubTime":"2026-08-11 08:39","pubTimestamp":1786408748,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到6月30日和7月31日公司股东人数是多少？谢谢汉森制药回复：尊敬的投资者您好，公司可在互动易平台回复非定期报告时点的月末股东人数，2026年6月30日的公司股东人数，将在2026年半年度报告中披露。截至2026年7月31日，公司含信用账户合并股东名册的股东总数为：33,940人。感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100006660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656348989","title":"股市必读：汉森制药新发布《关于收到全资子公司分红款的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2656348989","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656348989?lang=zh_cn&edition=full","pubTime":"2026-08-03 01:08","pubTimestamp":1785690493,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘，汉森制药报收于6.75元，上涨2.9%，换手率7.67%，成交量38.19万手，成交额2.57亿元。当日关注点交易信息汇总：7月31日主力资金净流出1881.63万元，占总成交额7.32%。公司公告汇总：公司于7月30日收到全资子公司云南永孜堂制药有限公司现金分红款2亿元。该分红事项已经公司第七届董事会第三次会议审议通过。本次利润分配将增加母公司财务报表利润总额，但对公司合并财务报表利润总额不产生实质性影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300000438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0039","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655807921","title":"股市必读：汉森制药（002412）新发布《关于收到全资子公司分红款的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655807921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655807921?lang=zh_cn&edition=full","pubTime":"2026-07-31 01:48","pubTimestamp":1785433698,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘，汉森制药报收于6.56元，下跌5.07%，换手率9.24%，成交量46.01万手，成交额3.08亿元。公司公告汇总：汉森制药于7月30日收到全资子公司云南永孜堂制药有限公司现金分红款2亿元。该分红事项已经公司第七届董事会第三次会议审议通过。本次利润分配将增加母公司财务报表利润总额，但对公司合并财务报表利润总额不产生实质性影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001392.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655877661","title":"汉森制药收到子公司永孜堂2亿元现金分红","url":"https://stock-news.laohu8.com/highlight/detail?id=2655877661","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655877661?lang=zh_cn&edition=full","pubTime":"2026-07-30 19:03","pubTimestamp":1785409380,"startTime":"0","endTime":"0","summary":"7月30日，汉森制药（002412）发布公告，公司收到全资子公司云南永孜堂制药有限公司的现金分红款2亿元。2026年一季度，汉森制药实现收入2.63亿元，归母净利润3841万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-07-30/doc-inikquqi1866735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0028","VIG","BK4585","BK4588","002412","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654889838","title":"汉森制药（002412）披露全资子公司利润分配公告，7月28日股价下跌4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654889838","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654889838?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:09","pubTimestamp":1785247758,"startTime":"0","endTime":"0","summary":"近日，湖南汉森制药股份有限公司披露《关于全资子公司利润分配的公告》。公告显示，公司于2026年7月28日召开第七届董事会第三次会议，审议通过《关于审议云南永孜堂制药有限公司2025年度利润分配预案的议案》。截至2025年12月31日，云南永孜堂制药有限公司累计未分配利润为333,713,825.60元，本次现金分红金额为200,000,000.00元，向公司分配红利，剩余未分配利润结转后续年度分配。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039622.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653746855","title":"7月23日汉森制药（002412）龙虎榜数据：机构净买入4425.6万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2653746855","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653746855?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:01","pubTimestamp":1784800901,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月23日公布的交易公开信息显示，汉森制药因连续三个交易日内，涨幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年7月23日收盘，汉森制药报收于7.38元，上涨9.99%，已连续涨停2天，换手率6.69%，成交量33.33万手，成交额2.36亿元。从龙虎榜公布的三日买卖数据来看，机构合计净买入4425.6万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300037094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","002412","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653879039","title":"异动快报：汉森制药（002412）7月23日9点38分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2653879039","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653879039?lang=zh_cn&edition=full","pubTime":"2026-07-23 09:40","pubTimestamp":1784770841,"startTime":"0","endTime":"0","summary":"证券之星7月23日盘中消息，9点38分汉森制药（002412）触及涨停板。其所属行业中药目前下跌。领涨股为汉森制药。该股为大农业，优化生育（三孩），流感概念热股。7月22日的资金流向数据方面，主力资金净流入4573.61万元，占总成交额18.46%，游资资金净流出1970.9万元，占总成交额7.95%，散户资金净流出2602.71万元，占总成交额10.5%。近5日资金流向一览见下表：汉森制药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300012789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0039","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653753291","title":"7月22日汉森制药涨10.00%，中欧量化先锋混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653753291","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653753291?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:50","pubTimestamp":1784710245,"startTime":"0","endTime":"0","summary":"证券之星消息，7月22日汉森制药涨10.00%，收盘报6.71元，换手率7.69%，成交量38.28万手，成交额2.48亿元。重仓汉森制药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为中欧基金的中欧量化先锋混合A。中欧量化先锋混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200034657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","002412","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651453749","title":"7月15日汉森制药涨9.49%，中欧量化先锋混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651453749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651453749?lang=zh_cn&edition=full","pubTime":"2026-07-15 16:29","pubTimestamp":1784104181,"startTime":"0","endTime":"0","summary":"证券之星消息，7月15日汉森制药涨9.49%，收盘报6.81元，换手率12.54%，成交量62.41万手，成交额4.18亿元。重仓汉森制药的公募基金请见下表：根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为中欧基金的中欧量化先锋混合A。中欧量化先锋混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500031031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0039","BK0028","BK0239","002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651103976","title":"汉森制药：预计2026年1-6月归属净利润盈利1.03亿元至1.16亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651103976","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651103976?lang=zh_cn&edition=full","pubTime":"2026-07-14 20:08","pubTimestamp":1784030907,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药发布业绩预告，预计2026年1-6月归属净利润盈利1.03亿元至1.16亿元。汉森制药2026年一季报显示，一季度公司主营收入2.63亿元，同比下降2.25%；归母净利润3840.64万元，同比上升241.17%；扣非净利润3608.52万元，同比上升295.83%；负债率11.36%，投资收益-1098.28万元，财务费用3.38万元，毛利率79.3%。本文数据来源于《汉森制药:2026年半年度业绩预告》，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400043878.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643279528","title":"6月15日汉森制药涨5.27%，东方量化成长灵活配置混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643279528","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2643279528?lang=zh_cn&edition=full","pubTime":"2026-06-15 16:45","pubTimestamp":1781513129,"startTime":"0","endTime":"0","summary":"证券之星消息，6月15日汉森制药涨5.27%，收盘报6.59元，换手率3.33%，成交量16.6万手，成交额1.08亿元。重仓汉森制药的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共1家，其中持有数量最多的公募基金为东方基金的东方量化成长灵活配置混合A。东方量化成长灵活配置混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061500020223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002412","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640941399","title":"汉森制药（002412）披露参股公司减少注册资本暨关联交易公告，6月2日股价下跌0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640941399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640941399?lang=zh_cn&edition=full","pubTime":"2026-06-02 22:45","pubTimestamp":1780411518,"startTime":"0","endTime":"0","summary":"截至2026年6月2日收盘，汉森制药报收于6.85元，较前一交易日下跌0.29%，最新总市值为34.47亿元。近日，湖南汉森制药股份有限公司披露《关于参股公司减少注册资本暨关联交易的公告》。公告显示，公司于2026年6月1日召开第七届董事会第二次会议，审议通过《关于参股公司减少注册资本暨关联交易的议案》。因公司实际控制人及副董事长在三银地产任职，本次交易构成关联交易。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200047578.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002412","BK0028","BK0239","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638854329","title":"汉森制药（002412）披露董事会完成换届选举及高级管理人员聘任公告，5月26日股价下跌2.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638854329","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638854329?lang=zh_cn&edition=full","pubTime":"2026-05-26 22:46","pubTimestamp":1779806778,"startTime":"0","endTime":"0","summary":"截至2026年5月26日收盘，汉森制药报收于6.62元，较前一交易日下跌2.07%，最新总市值为33.31亿元。该股当日开盘6.76元，最高6.77元，最低6.57元，成交额达6831.02万元，换手率为2.06%。近日，湖南汉森制药股份有限公司披露《关于董事会完成换届选举及聘任高级管理人员、财务总监、董事会秘书、内部审计负责人、证券事务代表的公告》。公告同时披露部分董事及高管离任情况，刘正清不再担任高管职务，傅建军等不再担任董事及高管。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052600041481.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638531380","title":"汉森制药(002412)4月30日股东户数3.23万户，较上期增加15.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638531380","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638531380?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:31","pubTimestamp":1779701493,"startTime":"0","endTime":"0","summary":"证券之星消息，近日汉森制药披露，截至2026年4月30日公司股东户数为3.23万户，较3月31日增加4396.0户，增幅为15.74%。在中药行业个股中，汉森制药股东户数低于行业平均水平，截至4月30日，中药行业平均股东户数为5.39万户。从股价来看，2026年3月31日至2026年4月30日，汉森制药区间涨幅为4.8%，在此期间股东户数增加4396.0户，增幅为15.74%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500024542.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0039","002412","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634291094","title":"股市必读：汉森制药(002412)股东户数3.23万户，较上期增加15.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2634291094","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2634291094?lang=zh_cn&edition=full","pubTime":"2026-05-11 04:09","pubTimestamp":1778443751,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，汉森制药报收于7.19元，上涨2.42%，换手率4.81%，成交量23.97万手，成交额1.71亿元。交易信息汇总资金流向5月8日主力资金净流出80.77万元；游资资金净流出603.88万元；散户资金净流入684.66万元。股本股东变化股东户数变动近日汉森制药披露，截至2026年4月30日公司股东户数为3.23万户，较3月31日增加4396.0户，增幅为15.74%。户均持股数量由上期的1.8万股减少至1.56万股，户均持股市值为10.88万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051100001906.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002412","BK0039"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633948826","title":"汉森制药：截至2026年4月30日，公司含信用账户合并股东名册的股东总数为","url":"https://stock-news.laohu8.com/highlight/detail?id=2633948826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633948826?lang=zh_cn&edition=full","pubTime":"2026-05-08 11:36","pubTimestamp":1778211395,"startTime":"0","endTime":"0","summary":"证券之星消息，汉森制药(002412)05月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至2026年4月30日公司的股东总数是多少？谢谢汉森制药回复：尊敬的投资者您好，截至2026年4月30日，公司含信用账户合并股东名册的股东总数为：32331人。感谢您对公司的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800017386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0039","002412","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787286656573,"stockEarnings":[{"period":"1week","weight":0.2616},{"period":"1month","weight":0.518},{"period":"3month","weight":0.4001},{"period":"6month","weight":0.3092},{"period":"1year","weight":0.4082},{"period":"ytd","weight":0.5136}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0102},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0437},{"period":"1year","weight":0.0365},{"period":"ytd","weight":-0.0164}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"湖南汉森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33940人(较上一季度增加4.98%)","perCapita":"14668股","listingDate":"2010-05-25","address":"湖南省益阳市赫山区银城大道2688号","registeredCapital":"50320万元","survey":" 湖南汉森制药股份有限公司的主营业务是中成药制剂、化学药等医用制剂的研发、生产和销售。公司的主要产品是四磨汤口服液、缩泉胶囊、银杏叶胶囊、愈伤灵胶囊、天麻醒脑胶囊、肠胃宁、利胆止痛胶囊、胃肠灵胶囊、固体口服制剂、液体口服制剂、注射剂。","listedPrice":35.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"汉森制药,002412,汉森制药股票,汉森制药股票老虎,汉森制药股票老虎国际,汉森制药行情,汉森制药股票行情,汉森制药股价,汉森制药股市,汉森制药股票价格,汉森制药股票交易,汉森制药股票购买,汉森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"汉森制药(002412)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供汉森制药(002412)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}